Europe Near Infrared Imaging Market

Market Introduction

Near infrared imaging is a noninvasive and relatively low-cost optical technique that is becoming a widely used instrument for measuring tissue O2 saturation, changes in hemoglobin volume and, indirectly, brain/muscle blood flow and muscle O2 consumption. NIR light (700-1000nm) penetrates superficial layers (skin, subcutaneous fat, skull, etc.) and is either absorbed by chromophores (oxy- and deoxyhemoglobin and myoglobin) or scattered within the tissue. Since it offers faster resolution and is less harmless to patients, it is beneficial over other strategies.

Market Overview and Dynamics

The Europe near infrared imaging market is expected to reach US$ 143.20 million in 2027 from US$ 106.42 million in 2019. The market is estimated to grow with a CAGR of 3.9% from 2020-2027. The growth of the market is attributed to some key driving factors such as the increasing burden of chronic diseases and rapid technological advancements and increased expenditure on healthcare. However, the market growth is likely to be hindered owing to the lack of trained staff to perform near-infrared imaging.

Key Market Segments

Based on product, the near infrared imaging market is segmented device and reagent. The device segmented is further subdivided into near-infrared fluorescence imaging systems and near-infrared fluorescence and bioluminescence imaging systems. The reagent segment is further subdivided into indocyanine green (ICG) and others. Based on application, the near infrared imaging market, is segmented into cancer surgeries, cardiovascular surgeries, gastrointestinal surgeries, plastic/reconstructive surgeries, preclinical imaging, and others. Based on end user, the near infrared imaging market, is segmented into hospitals and clinics, pharmaceutical and biotechnology companies, and research laboratories.

Major Sources and Companies Listed

Some of the major primary and secondary sources for near infrared imaging market included in the report are European Cardiovascular Disease Statistics, Globocan, German Society for Thoracic and Cardiovascular Surgery (GSTCVS), and others.

Reasons to buy the report

• To understand the Europe near infrared imaging market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for near infrared imaging market
• Efficiently plan M&A and partnership deals in Europe near infrared imaging market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Near infrared imaging market
• Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region

EUROPE NEAR INFRARED IMAGING MARKET SEGMENTATION

By Product

• Device
  • Near-Infrared Fluorescence Imaging Systems
  • Near-Infrared Fluorescence and Bioluminescence Imaging Systems
• Reagent
  • Indocyanine Green (ICG)
  • Others

By Application

• Cancer Surgeries
• Cardiovascular Surgeries
• Gastrointestinal Surgeries
• Plastic/Reconstructive Surgeries
• Preclinical Imaging
• Others

By End User

• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Research Laboratories

By Country

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Company Profiles

• KARL STORZ SE & Co. KG
• Olympus Corporation
• Carl Zeiss Meditec AG
• Leica Microsystems Nussloch GmbH
• Perkin Elmer, Inc.
• LI-COR, Inc.
• Hamamatsu Photonics K.K.
• Quest Medical Imaging B.V.
• Mizuho Medical Co,Ltd.
• SHIMADZU CORPORATION

Europe Near Infrared Imaging Market Strategic Insights

Europe Near Infrared ImagingMarket Report Highlights

Europe Near Infrared Imaging Market Country and Regional Insights